Direct-Acting Antivirals (DAAs)

Direct-Acting Antivirals (DAAs) are a class of medications used to treat hepatitis C virus (HCV) infection. They work by targeting specific proteins that the virus needs to replicate and spread in the body. By blocking these proteins, DAAs prevent the virus from multiplying, allowing the immune system to clear the infection more effectively. These medications are highly effective, usually cure hepatitis C in 8 to 12 weeks, and have fewer side effects compared to older treatments. DAAs have revolutionized hepatitis C treatment, providing a safe, fast, and simple option for achieving viral cure.